Variant report

Variant	nsv556994
Chromosome Location	chr12:1737309-1743843
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr12:1738484-1738761	HepG2	liver:	n/a	n/a
2	BHLHE40	chr12:1739255-1739262	GM12878	blood:	n/a	n/a
3	BHLHE40	chr12:1738508-1738632	GM12878	blood:	n/a	n/a
4	BHLHE40	chr12:1743775-1744107	K562	blood:	n/a	n/a
5	CREB1	chr12:1739249-1739495	A549	lung:	n/a	n/a
6	CREB1	chr12:1743762-1744107	A549	lung:	n/a	n/a
7	CTBP2	chr12:1738253-1739969	H1-hESC	embryonic stem cell:	n/a	n/a
8	CTCF	chr12:1739060-1739210	AoAF	blood vessel:	n/a	chr12:1739121-1739134 chr12:1739119-1739137
9	CTCF	chr12:1739081-1739175	H1-hESC	embryonic stem cell:	n/a	chr12:1739121-1739134 chr12:1739119-1739137
10	CTCF	chr12:1739220-1739370	HVMF	connective:	n/a	chr12:1739311-1739324 chr12:1739309-1739327 chr12:1739247-1739265
11	CTCF	chr12:1740600-1740750	HAc	cerebellar:	n/a	n/a
12	CTCF	chr12:1739140-1739290	HA-sp	spinal cord:	n/a	chr12:1739247-1739265
13	CTCF	chr12:1739570-1739798	MCF-7	breast:	n/a	chr12:1739583-1739596
14	CTCF	chr12:1738720-1738870	SAEC	small airway:	n/a	n/a
15	CTCF	chr12:1738587-1738650	GM12878	blood:	n/a	chr12:1738587-1738605
16	CTCF	chr12:1739060-1739210	HEK293	kidney:	n/a	chr12:1739121-1739134 chr12:1739119-1739137
17	CTCF	chr12:1739020-1739170	WERI-Rb-1	eye:	n/a	chr12:1739121-1739134 chr12:1739119-1739137
18	CTCF	chr12:1740540-1740690	HCFaa	heart:	n/a	n/a
19	CTCF	chr12:1739297-1739378	GM13976	blood:	n/a	chr12:1739311-1739324 chr12:1739309-1739327
20	CTCF	chr12:1739120-1739270	Caco-2	colon:	n/a	chr12:1739247-1739265 chr12:1739121-1739134
21	CTCF	chr12:1743800-1744097	A549	lung:	n/a	chr12:1743945-1743958 chr12:1743943-1743959 chr12:1743942-1743960 chr12:1743947-1743957 chr12:1743944-1743965
22	CTCF	chr12:1739500-1739650	HRPEpiC	eye:	n/a	chr12:1739583-1739596
23	CTCF	chr12:1739600-1739750	HRE	kidney:	n/a	n/a
24	CTCF	chr12:1739586-1739808	NHEK	skin:	n/a	n/a
25	CTCF	chr12:1743604-1744149	GM12878	blood:	n/a	chr12:1743945-1743958 chr12:1743682-1743689 chr12:1743943-1743959 chr12:1743942-1743960 chr12:1743947-1743957 chr12:1744090-1744098 chr12:1743944-1743965
26	CTCF	chr12:1739580-1739730	SK-N-SH_RA	brain:	n/a	chr12:1739583-1739596
27	CTCF	chr12:1739700-1739850	HCT-116	colon:	n/a	n/a
28	CTCF	chr12:1739640-1739790	NHEK	skin:	n/a	n/a
29	CTCF	chr12:1743819-1744094	GM19239	blood:	n/a	chr12:1743945-1743958 chr12:1743943-1743959 chr12:1743942-1743960 chr12:1743947-1743957 chr12:1743944-1743965
30	CTCF	chr12:1739060-1739210	GM12871	blood:	n/a	chr12:1739121-1739134 chr12:1739119-1739137
31	CTCF	chr12:1740400-1740550	AG04450	lung:	n/a	n/a
32	CTCF	chr12:1739040-1739190	GM12869	blood:	n/a	chr12:1739121-1739134 chr12:1739119-1739137
33	CTCF	chr12:1743169-1744525	SK-N-SH	brain:	n/a	chr12:1743945-1743958 chr12:1743682-1743689 chr12:1743943-1743959 chr12:1743942-1743960 chr12:1743947-1743957 chr12:1744090-1744098 chr12:1743944-1743965
34	CTCF	chr12:1739140-1739290	GM12872	blood:	n/a	chr12:1739247-1739265
35	CTCF	chr12:1739581-1739815	MCF-7	breast:	n/a	chr12:1739583-1739596
36	CTCF	chr12:1743595-1744146	IMR90	lung:	n/a	chr12:1743945-1743958 chr12:1743682-1743689 chr12:1743943-1743959 chr12:1743942-1743960 chr12:1743947-1743957 chr12:1744090-1744098 chr12:1743944-1743965
37	CTCF	chr12:1740560-1740710	HA-sp	spinal cord:	n/a	n/a
38	CTCF	chr12:1739100-1739250	GM12878	blood:	n/a	chr12:1739121-1739134 chr12:1739119-1739137
39	CTCF	chr12:1739580-1739730	AG10803	skin:	n/a	chr12:1739583-1739596
40	CTCF	chr12:1739740-1739890	HCM	heart:	n/a	n/a
41	CTCF	chr12:1739293-1739387	Pancreas_OC	pancreas:	n/a	chr12:1739311-1739324 chr12:1739309-1739327
42	CTCF	chr12:1743753-1744105	HepG2	liver:	n/a	chr12:1743945-1743958 chr12:1743943-1743959 chr12:1743942-1743960 chr12:1743947-1743957 chr12:1744090-1744098 chr12:1743944-1743965
43	CTCF	chr12:1739268-1739725	IMR90	lung:	n/a	chr12:1739583-1739596 chr12:1739411-1739424 chr12:1739311-1739324 chr12:1739309-1739327
44	CTCF	chr12:1739000-1739150	NB4	blood:	n/a	chr12:1739121-1739134 chr12:1739119-1739137
45	CTCF	chr12:1742940-1743090	BE2_C	brain:	n/a	n/a
46	CTCF	chr12:1739240-1739247	GM19239	blood:	n/a	n/a
47	CTCF	chr12:1738500-1738650	BE2_C	brain:	n/a	chr12:1738587-1738605
48	CTCF	chr12:1740400-1740550	HAc	cerebellar:	n/a	n/a
49	CTCF	chr12:1739600-1739750	HMEC	breast:	n/a	n/a
50	CTCF	chr12:1739520-1739670	GM12874	blood:	n/a	chr12:1739583-1739596

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:1739687-1739737	HPAEpiC	pulmonary alveolar:	n/a
2	chr12:1739687-1739737	HPAEpiC	pulmonary alveolar:	n/a
3	chr12:1739917-1739967	A549	lung:	n/a
4	chr12:1739687-1739737	LNCaP	prostate:	n/a
5	chr12:1738268-1738318	NT2-D1	testis:	n/a
6	chr12:1738292-1738342	ProgFib	skin:	n/a
7	chr12:1739687-1739737	K562	blood:	n/a
8	chr12:1739061-1739111	GM06990	blood:	n/a
9	chr12:1739061-1739111	HCF	heart:	n/a
10	chr12:1739917-1739967	MCF-7	breast:	n/a
11	chr12:1739061-1739111	BE2_C	brain:	n/a
12	chr12:1739832-1739882	HCM	heart:	n/a
13	chr12:1742536-1742586	SK-N-SH	brain:	n/a
14	chr12:1738292-1738342	GM12891	blood:	n/a
15	chr12:1739917-1739967	HAEpiC	amniotic membrane:	n/a
16	chr12:1738337-1738387	NT2-D1	testis:	n/a
17	chr12:1742536-1742586	A549	lung:	n/a
18	chr12:1739061-1739111	AG04450	lung:	fetal
19	chr12:1741869-1741919	Jurkat	blood:	n/a
20	chr12:1738035-1738085	GM12878	blood:	n/a
21	chr12:1738446-1738496	SK-N-SH_RA	brain:	n/a
22	chr12:1738268-1738318	A549	lung:	n/a
23	chr12:1742536-1742586	NB4	blood:	n/a
24	chr12:1738110-1738160	SAEC	small airway:	n/a
25	chr12:1738035-1738085	GM06990	blood:	n/a
26	chr12:1738337-1738387	RPTEC	kidney:	n/a
27	chr12:1739061-1739111	HepG2	liver:	n/a
28	chr12:1739061-1739111	HCPEpiC	choroid plexus:	n/a
29	chr12:1741869-1741919	GM12878	blood:	n/a
30	chr12:1738337-1738387	NHBE	bronchial:	n/a
31	chr12:1738035-1738085	BE2_C	brain:	n/a
32	chr12:1739832-1739882	AG10803	skin:	n/a
33	chr12:1739917-1739967	Hela-S3	cervix:	n/a
34	chr12:1739832-1739882	AG09309	skin:	n/a
35	chr12:1739832-1739882	LNCaP	prostate:	n/a
36	chr12:1738110-1738160	NHDF-neo	bronchial:	n/a
37	chr12:1741869-1741919	U87	brain:	n/a
38	chr12:1738060-1738110	GM12891	blood:	n/a
39	chr12:1739061-1739111	AG09319	gingival:	n/a
40	chr12:1739832-1739882	HNPCEpiC	eye:	n/a
41	chr12:1739917-1739967	HIPEpiC	eye:	n/a
42	chr12:1738337-1738387	HRE	kidney:	n/a
43	chr12:1739687-1739737	AG09319	gingival:	n/a
44	chr12:1741869-1741919	Hela-S3	cervix:	n/a
45	chr12:1739917-1739967	HNPCEpiC	eye:	n/a
46	chr12:1738446-1738496	GM12878	blood:	n/a
47	chr12:1741869-1741919	SK-N-SH	brain:	n/a
48	chr12:1738337-1738387	AoSMC	blood vessel:	n/a
49	chr12:1738446-1738496	MCF-7	breast:	n/a
50	chr12:1738035-1738085	GM19239	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr12:1743835..1744388-chr12:2048853..2049575,2	K562	blood:
2	chr12:1738204..1740242-chr12:1742756..1744844,2	K562	blood:
3	chr12:1738742..1741489-chr12:1743344..1746284,2	K562	blood:
4	chr12:1740865..1743090-chr12:1799142..1801895,2	MCF-7	breast:
5	chr12:1741431..1743986-chr12:1900425..1902270,2	MCF-7	breast:
6	chr12:1743763..1744406-chr12:1900002..1900715,3	K562	blood:
7	chr12:1741511..1744510-chr12:1943871..1945697,2	K562	blood:
8	chr12:1714212..1714749-chr12:1739345..1739945,2	MCF-7	breast:
9	chr12:1702532..1704125-chr12:1743682..1745521,2	MCF-7	breast:
10	chr12:1743461..1744388-chr12:1899911..1900896,5	MCF-7	breast:
11	chr12:1703157..1705505-chr12:1739226..1741204,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ADIPOR2-3	chr12:1740464-1740489	NONHSAT025406

Variant related genes	Relation type
WNT5B	TF binding region
WNT5B	CpG island
ENSG00000171823	chromatin interactions
ENSG00000111186	chromatin interactions
ENSG00000006831	chromatin interactions

Extended variants
information (count: 270 )
Associated
traits (count: 82 )

Variant overlapped rSNPs/rCNVs (count:270 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10773969	chr12:1737309-1737310	Weak transcription Strong transcription Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs10773970	chr12:1737320-1737321	Weak transcription Strong transcription Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs59145675	chr12:1737327-1737328	Weak transcription Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs576495796	chr12:1737365-1737366	Weak transcription Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs12307093	chr12:1737380-1737381	Weak transcription Strong transcription Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs146913761	chr12:1737390-1737391	Weak transcription Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs148374356	chr12:1737403-1737404	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs542940929	chr12:1737415-1737416	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs561522239	chr12:1737416-1737417	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs532048675	chr12:1737425-1737426	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs550371088	chr12:1737447-1737448	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs565497724	chr12:1737450-1737451	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs374434933	chr12:1737457-1737458	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs532486981	chr12:1737511-1737512	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs577667588	chr12:1737516-1737517	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs565938110	chr12:1737532-1737533	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs536691600	chr12:1737544-1737545	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs548180209	chr12:1737552-1737553	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs539295824	chr12:1737555-1737556	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs373864058	chr12:1737578-1737579	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs10848538	chr12:1737580-1737581	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs141548995	chr12:1737583-1737584	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs576993960	chr12:1737584-1737585	Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs534414249	chr12:1737632-1737633	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Strong transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs553071485	chr12:1737750-1737751	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Strong transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs574455466	chr12:1737937-1737938	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Strong transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs150457558	chr12:1737978-1737979	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Strong transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs138251035	chr12:1738002-1738003	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs12425600	chr12:1738003-1738004	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs544164066	chr12:1738014-1738015	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs554537189	chr12:1738086-1738087	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs534379382	chr12:1738087-1738088	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs3803166	chr12:1738105-1738106	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs28384801	chr12:1738111-1738112	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
35	rs541158632	chr12:1738114-1738115	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs538567222	chr12:1738126-1738127	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
37	rs559759024	chr12:1738160-1738161	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs530156458	chr12:1738200-1738201	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs373799013	chr12:1738209-1738210	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs548142627	chr12:1738214-1738215	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs58222030	chr12:1738215-1738216	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs3803165	chr12:1738216-1738217	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs552096315	chr12:1738217-1738218	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs570542251	chr12:1738218-1738219	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs36118160	chr12:1738245-1738246	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs397850609	chr12:1738250-1738251	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs534772751	chr12:1738270-1738271	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
48	rs552892904	chr12:1738271-1738272	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
49	rs186765649	chr12:1738292-1738293	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
50	rs544590180	chr12:1738298-1738299	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:82)

Disease	PMID	Source
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Cancer	20164919	CNVD
Pancreatic cancer	17952125	CNVD
Lung adenocarcinoma	21935476	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:691 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:1715400-1738600	Weak transcription	Right Atrium	heart
2	chr12:1721800-1738600	Weak transcription	Fetal Brain Female	brain
3	chr12:1724000-1737600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
4	chr12:1732200-1738400	Weak transcription	Brain Anterior Caudate	brain
5	chr12:1732200-1738400	Weak transcription	Esophagus	oesophagus
6	chr12:1732400-1738000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
7	chr12:1733000-1744000	Weak transcription	K562	blood
8	chr12:1734600-1738200	Strong transcription	Primary neutrophils fromperipheralblood	blood
9	chr12:1734600-1738200	Weak transcription	Rectal Smooth Muscle	rectum
10	chr12:1734600-1738400	Weak transcription	Colon Smooth Muscle	Colon
11	chr12:1734800-1737800	Weak transcription	HSMMtube	muscle
12	chr12:1734800-1738200	Weak transcription	Duodenum Smooth Muscle	Duodenum
13	chr12:1734800-1738200	Weak transcription	Rectal Mucosa Donor 31	rectum
14	chr12:1734800-1738200	Weak transcription	HSMM	muscle
15	chr12:1734800-1738200	Weak transcription	NHLF	lung
16	chr12:1734800-1738400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
17	chr12:1734800-1738400	Weak transcription	Pancreas	Pancrea
18	chr12:1735000-1737600	Weak transcription	Cortex derived primary cultured neurospheres	brain
19	chr12:1735000-1737600	Weak transcription	Rectal Mucosa Donor 29	rectum
20	chr12:1735000-1738200	Weak transcription	Duodenum Mucosa	Duodenum
21	chr12:1735000-1738400	Weak transcription	NH-A	brain
22	chr12:1735200-1737600	Weak transcription	Fetal Stomach	stomach
23	chr12:1735200-1737800	Weak transcription	Fetal Muscle Trunk	muscle
24	chr12:1735200-1738400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr12:1735400-1738000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
26	chr12:1735400-1738000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
27	chr12:1735400-1738200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr12:1735400-1738200	Weak transcription	Muscle Satellite Cultured Cells	--
29	chr12:1735400-1738400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr12:1736200-1737400	Genic enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
31	chr12:1736200-1738000	Genic enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr12:1736600-1737800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
33	chr12:1736600-1738600	Weak transcription	Ovary	ovary
34	chr12:1736800-1737800	Strong transcription	Osteobl	bone
35	chr12:1737000-1737800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
36	chr12:1737200-1737800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
37	chr12:1737200-1737800	Weak transcription	NHDF-Ad	bronchial
38	chr12:1737200-1738200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
39	chr12:1737400-1737600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
40	chr12:1737400-1737800	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
41	chr12:1737400-1738000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
42	chr12:1737400-1738400	Bivalent Enhancer	Fetal Muscle Leg	muscle
43	chr12:1737600-1737800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
44	chr12:1737600-1737800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
45	chr12:1737600-1737800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
46	chr12:1737600-1738000	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
47	chr12:1737600-1738000	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
48	chr12:1737600-1738000	Enhancers	Fetal Stomach	stomach
49	chr12:1737600-1738200	Enhancers	Rectal Mucosa Donor 29	rectum
50	chr12:1737600-1738600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links